Background
Initial prescribed medicines are often a “trial and error” decision. For example, 38% of depression patients will not respond to their initial treatments*. We believe that by taking our tests these figures can be reduced dramatically. This test is provided by Genomind through its exclusive UK partnership with Myogenes.
Why Myogenes Psychiatric Pharmacogenetic test?
If you’re living with mental illness, you’ll know that the correct treatment and medication makes all the difference. And, in the current climate of ever changing lockdown restrictions, getting the most effective treatment and medication has never been more important.
That’s why this genetic test has been designed to help your doctor quickly make the right treatment decisions for you. In fact, by identifying your specific genetic markers, it can both indicate which treatments are likely to be the most effective for you and what dosage should be prescribed as well as helping you avoid any treatments that are likely to result in adverse effects.
Our Psychiatric Pharmacogenetics test is specifically tailored to help guide treatment options for a range of psychiatric conditions, these include the following:
- Depression
- Anxiety
- Obsessive Compulsive Disorder (OCD)
- Attention Deficit Hyperactivity Disorder (ADHD)
- Bipolar Disorder
- Post-Traumatic Stress Disorder (PTSD)
- Autism
- Schizophrenia
- Chronic pain
- Substance abuse
